JPMorgan raises Novo Nordisk stock price target on Ozempic outlook
JPMorgan raises Novo Nordisk stock price target on Ozempic outlook Investing.com
Covered in this story
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.